Table 2.
SCFAs | Histone/non-histone | PTMs changes | Model | Roles | Ref |
---|---|---|---|---|---|
Acetate | NIP45 | Methylation | T-cell | Acetate alters DNA methylation in the region of activated Treg cells, regulates Treg cell proliferation and enhances the anti-inflammatory effect of immune cells. | (109) |
Acetate | Foxp3 H3K9ac | Acetylation | T-cell | Acetate may increase acetylation of the Foxp3 promoter through HDAC9 inhibition by increasing the number and function of T regulatory cells and significant airway inflammatory responses. | (117) |
Acetate | p70-S6K | Acetylation | T-cell | The inhibitory effect of SCFA on HDAC in T-cells increases acetylation of p70 S6 kinase and promotes T-cell differentiation into effector and regulatory T-cells, thereby promoting immunity or immune tolerance depending on the immune environment. | (120) |
propionate | H3K9ac | Acetylation | cTregs | Propionic acid treatment of cTregs enhanced histone H3K9ac through inhibition of HDAC, which in turn affected the immune status of cTregs. | (115) |
Pentanoate | H4 | Acetylation | Th17 cell | Pentanoate promotes histone H4 acetylation by providing acetyl coenzyme A and inhibiting the activity of HDAC, induces IL-10 production by lymphocytes by increasing acetylation at the IL-10 promoter, and improves anti-inflammatory capacity. | (119) |
Butyrate | H3 | Acetylation | CD4+ T cells | Exogenous addition of butyrate enhances histone H3 acetylation in the promoter and conserved non-coding sequence regions of the Foxp3 locus, induces differentiation of mouse colonic T-cells and ameliorates the development of colitis. | (118) |
Butyrate | H3K9ac/ H3K9me3 |
Acetylation | CD4+ T cells | Butyrate protects the host from inflammation by increasing the binding of HIF1α to the IL-22 promoter through histone modifications and promoting IL-22 production. | (121) |
Butyrate | H3K9ac | Acetylation | BMDM | Butyrate maintains tolerance to intestinal microbiota by inhibiting the activity of HDAC, promoting Nos2, IL-6 and H3K9ac, the promoter region of the IL12b gene, and by down-regulating the release of pro-inflammatory factors that reduce the response of macrophages to commensal bacteria. | (7) |
Butyrate | GPR41/ GPR43 |
Methylation | Cecal Tissues | Butyrate inhibits the methylation of the GPR41/43 promoter region and thus the expression of GPR41/43, reducing inflammatory damage. | (103) |
Butyrate | H3K18cr | Crotonylation | Colon epithelial cell | Butyrate promotes histone crotonylation by inhibiting the activity of HDAC in colonic epithelial cells. | (129) |
Butyrate/ Propionate |
Foxp3 | Acetylation | peripheral regulatory T-cell | Butyrate and propionate increase acetylation of Foxp3 to promote extrathymic Treg cell differentiation by inhibiting HDAC activity. | (104) |
Butyrate/ Propionate |
H4K12ac | Acetylation | BMDM | Treatment of bone marrow cells with butyrate and propionate resulted in upregulation of H4K12ac on the PU.1 promoter, inhibiting the expression of PU.1 and RelB and thus preventing DC development. | (111) |
isobutyric/ propionic |
H3K27ac/ H3K27me3 |
Acetylation | T-cell | SCFAs regulates host antiviral innate immune response by increasing histone acetylation and decreasing repressive histone methylation to coordinate viral transcriptional activation. | (116) |